Your browser doesn't support javascript.
loading
Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study.
Hermiller, James B; Rutledge, David R; Gruberg, Luis; Katopodis, John N; Lombardi, William; Mao, Vivian W; Zhao, Weiying; Sharma, Samin K; Tamboli, Hoshedar P; Wang, Jin; Jonnavithula, Lalitha; Sudhir, Krishnankutty; Krucoff, Mitchell W.
Affiliation
  • Hermiller JB; St. Vincent Heart Center of Indiana, Indianapolis, Indiana, USA. jhermill@TheCareGroup.com
J Interv Cardiol ; 25(6): 565-75, 2012 Dec.
Article in En | MEDLINE | ID: mdl-22998355
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Cardiovascular Agents / Sirolimus / Drug-Eluting Stents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Interv Cardiol Journal subject: CARDIOLOGIA Year: 2012 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Cardiovascular Agents / Sirolimus / Drug-Eluting Stents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Interv Cardiol Journal subject: CARDIOLOGIA Year: 2012 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos